News & Articles

During the American Association for Cancer Research 2018 Annual Meeting, SelectScience recognized cutting-edge products and technologies advancing life sciences research

The trial demonstrates that first-line pembrolizumab treatment improved overall and progression-free survival rates in patients with metastatic nonsquamous non-small cell lung cancer

The primary endpoint for first-line nivolumab-ipilimumab combo trial indicates improved progression-free survival in patients with advanced non-small cell lung cancer

Expansion of circulating tumor-specific T cells after nivolumab treatment suggests systemic antitumor immunity in patients with resectable lung cancer

The FT819 CAR T cell line has the potential to be mass-produced, stored, and made readily available for cancer immunotherapy

A recent study from University of Edinburgh aims to pinpoint genes that may be associated with depression

Crizotinib yielded a high objective response rate for adult patients with ALK-positive Inflammatory myofibroblastic tumor, and a 100 percent disease control rate

Team heading to Chicago, USA, to interview scientists at the forefront of cancer research and report on the newest technologies

Recent discoveries by researchers at Stanford University has provided new insights into the complex mechanisms of concussion

Single software solution helps manage the entire laboratory process across all analytical techniques

OMNIC Anywhere cloud-based sharing and data analysis application facilitates collaboration through 24/7 access to FTIR spectrometers data

Purpose-built, flexible LIMS solutions save time and money for pharma, food & beverage, oil & gas, and diagnostics